Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Response to statement made by Andor Technology plc

12 Nov 2013 15:06

RNS Number : 8401S
Oxford Instruments PLC
12 November 2013
 



12 November 2013

 

 

Oxford Instruments plc

 

Response to statement made by Andor Technology plc

 

Oxford Instruments plc ("Oxford Instruments" or the "Company") notes the recent announcement made by Andor Technology plc ("Andor").

 

Oxford Instruments has a high regard for the Andor business and its employees and is grateful for the Board of Andor's constructive engagement in the ongoing discussions.

 

Oxford Instruments is developing its business in the Nano-Bio field and believes that the acquisition of Andor has significant industrial and commercial logic. Having substantially completed its due diligence, Oxford Instruments believes that the indicative offer of 500p per share in cash represents an attractive proposal to Andor shareholders.

 

Oxford Instruments looks forward to continuing discussions with the Board of Andor and working with it towards a recommended transaction.

 

Ends

 

Enquiries:

 

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

MHP Communications Tel: 020 3128 8100

Rachel Hirst

Rory King

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RSPGGGUUGUPWGAP

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.